European Healthtech startup funding raised during Q4 2012.
In Q4 2012, 25 European Healthtech companies raised a combined €134M across 25 funding rounds, down 21.6% versus Q4 2011. Switzerland led by capital raised, and Amadeus Capital Partners was the most active investor. Data as of 7 Aug 2026.
1 exit.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Biocartis | Series D+ | Dec 2012 | €35M |
| Endosense | Series C | Nov 2012 | €31M |
| NeRRe Therapeutics | Series A | Dec 2012 | €14M |
| EarlySense | Series D+ | Nov 2012 |
| €12M |
| GlySure | Series C | Nov 2012 | €10M |
| Biom'Up | Early VC | Oct 2012 | €6.8M |
| NovImmune | Grant | Oct 2012 | €6.0M |
| Cardiosonic | Series B | Dec 2012 | €4.7M |
| Qinec | Series B | Nov 2012 | €1.9M |
| OR Productivity | Early VC | Dec 2012 | €1.5M |
| BiOxyDyn | Early VC | Oct 2012 | €1.5M |
| Calcivis | Early VC | Nov 2012 | €1.5M |
| SelfDiagnostics | Grant | Nov 2012 | €1.4M |
| Morria Biopharmaceuticals | Other | Dec 2012 | €1.4M |
| Blackford Analysis | Seed | Nov 2012 | €1.0M |
